Page 239 - Genentech News Today

The COVID-19 At-Home Test that tens of millions of Americans received via the U.S. government is now available over-the-counter nationwide under t...

Ha, the newly named George Austin Director, has been with WSU since 2005 and is the director of the O.H. Reaugh Laboratory for Oil and Gas Processing.

NEW YORK and MAINZ, GERMANY, November 10, 2022 - Pfizer Inc.(Nasdaq: BNTX) today announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY Original/Omicron BA.4/BA.5

Curis, Inc. , a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its business update and financial results for the third quarter... | November 10, 2022

Microbiome clinical trial pipeline constitutes 130+ key companies continuously working towards developing 200+ microbiome drugs, analyzes DelveInsight LAS VEGAS, Nov. 9, 2022 /PRNewswire/

LOS ANGELES, Nov. 8, 2022 /PRNewswire/ -- Aadi Bioscience, Inc. , a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR... | November 9, 2022

WASHINGTON, Nov. 9, 2022 /PRNewswire/ -- This Lung Cancer Awareness Month, the global LCAM Coalition has launched a six-country digital and social...

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, today announced that final data from its...

/PRNewswire/ -- DelveInsights Microbiome Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed, and pipeline...

Investegate announcements from Oxford BioDynamics, Director/PDMR Shareholding